Dr. Gudmundur Hrafn Gudmundsson
University of Iceland and Karolinska Institute
Biography & Research Background
Gudmundur Hrafn Gudmundsson is a Professor at the University of Iceland and Karolinska Institutet (Sweden). He played a foundational role in the discovery of LL-37, cloning the FALL-39 gene and isolating the mature peptide from human neutrophils. His work established the processing mechanism of the precursor protein hCAP18 into the active antimicrobial peptide LL-37. Key publications: 'FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis' (1995), 'The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes' (1996), and 'Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37' (1998). Gudmundur Hrafn Gudmundsson is referenced as a foundational scientist in LL-37 research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Gudmundur Hrafn Gudmundsson is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Gudmundur Hrafn Gudmundsson is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.
